TipRanks
Poolbeg Pharma Ltd. (DE:7JN)
FRANKFURT:7JN
Germany Market
7JN
Poolbeg Pharma Ltd.
RESEARCH TOOLSreports

Poolbeg Pharma Ltd. (7JN) Income Statement

1 Followers

Poolbeg Pharma Ltd. Income Statement

Last quarter (Q2 2026), Poolbeg Pharma Ltd.'s total revenue was £0.00, a decrease of ― from the same quarter last year. In Q2, Poolbeg Pharma Ltd.'s net income was £-1.94M. See Poolbeg Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 0.00£ 0.00£ 0.00£ 0.00£ 0.00
Gross Profit
£ -59.00K£ -114.00K£ -26.00K£ -26.00K£ -18.00K
Operating Expenses
£ 6.36M£ 6.37M£ 5.04M£ 4.99M£ 2.36M
Depreciation and Amortization
£ 59.00K£ 114.00K£ 26.00K£ 26.00K£ 18.00K
EBITDA
£ -6.36M£ -6.00M£ -4.66M£ -4.75M£ -2.32M
Operating Income
£ -6.42M£ -6.62M£ -5.04M£ -4.99M£ -2.38M
Other Income/Expenses
£ 640.00K£ 674.00K£ 534.00K£ 209.00K£ 42.00K
Pretax Income
£ -5.77M£ -5.94M£ -4.50M£ -4.78M£ -2.34M
Net Income
£ -5.70M£ -5.79M£ -3.93M£ -4.69M£ -2.34M
Per Share Metrics
Basic EPS
£ >-0.01£ -0.01£ -7.90£ -9.37£ -4.67
Diluted EPS
£ >-0.01£ -0.01£ -7.86£ -9.37£ -4.67
Weighted Average Shares Outstanding
 602.65M 499.14M 497.59M 500.00M 500.00M
Weighted Average Shares Outstanding (Diluted)
 602.65M 500.00M 497.59M 500.00M 500.00M
Currency in GBP

Poolbeg Pharma Ltd. Earnings and Revenue History